This document summarizes the research being conducted in Michael R. Johnston's Mesothelioma Research Program. The program focuses on early detection studies using LDCT scans and biomarkers, treatment protocols including trimodality therapy and new therapies, and basic research studies in genetic profiling and immunomodulation. Survival rates and sites of recurrence are presented for patients receiving adjuvant trials and trimodality therapy. Complications and outcomes are discussed for EPP surgery and hemithoracic radiation. Preliminary results are also presented from an early detection study using LDCT scans in high-risk asbestos workers, finding several mesothelioma and lung cancers.